HANSA BIOPHARMA AB NPV earnings per share and revenue

0RC7 earnings per share for the last quarter are -4.15 SEK whereas the estimation was -3.46 SEK which accounts for -19.94% surprise. Företagets omsättning för samma period uppgår till 56.00 M SEK trots den uppskattade siffran 54.04 M SEK. Estimated earnings per share for the next quarter are -2.78 SEK, and revenue is expected to reach 54.27 M SEK. Also watch annual changes over time to get a bigger picture of 0RC7 earnings per share and revenue dynamics.